![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Long-term Follow-up of Patients Treated With Sofosbuvir in the Phase 3 Studies FISSION, POSITRON, FUSION, and NEUTRINO
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Wendy Cheng,1 Stephen Shafran,2 Kimberly Beavers,3 Hongmei Mo,4 John McNally,4 Diana M. Brainard,4 William T. Symonds,4 Mario Chojkier,5 Alessandra Mangia,6 Christian Schwabe7
1Royal Perth Hospital, Perth, Western Australia, Australia; 2University of Alberta, Edmonton, Canada; 3Asheville Gastroenterology Associates, Asheville, North Carolina, USA; 4Gilead Sciences, Inc., Foster City, California, USA;
5University of California, San Diego; 6Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 7Auckland Clinical Studies, Auckland, New Zealand
![EASL1.gif](../images/042114/042114-9/EASL1.gif)
![EASL2.gif](../images/042114/042114-9/EASL2.gif)
![EASL3.gif](../images/042114/042114-9/EASL3.gif)
![EASL4.gif](../images/042114/042114-9/EASL4.gif)
![EASL5.gif](../images/042114/042114-9/EASL5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|